WallStSmart

MiniMed Group, Inc. Common Stock (MMED)vsOmada Health, Inc. Common Stock (OMDA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MiniMed Group, Inc. Common Stock generates 1009% more annual revenue ($2.89B vs $260.21M). OMDA leads profitability with a -4.9% profit margin vs -7.3%. OMDA earns a higher WallStSmart Score of 37/100 (F).

MMED

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 3.5Value: 5.0Quality: 5.0

OMDA

Hold

37

out of 100

Grade: F

Growth: 8.0Profit: 2.5Value: 5.0Quality: 5.8
Piotroski: 5/9Altman Z: -1.74

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MMED0 strengths · Avg: 0/10

No standout strengths identified

OMDA1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
58.1%10/10

Revenue surging 58.1% year-over-year

Areas to Watch

MMED4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Free Cash FlowQuality
$-53.00M2/10

Negative free cash flow — burning cash

OMDA4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$796.08M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
4.3%3/10

Operating margin of 4.3%

Return on EquityProfitability
-8.7%2/10

ROE of -8.7% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : MMED

Revenue growth of 13.1% demonstrates continued momentum.

Bull Case : OMDA

The strongest argument for OMDA centers on Revenue Growth. Revenue growth of 58.1% demonstrates continued momentum.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.

Bear Case : OMDA

The primary concerns for OMDA are EPS Growth, Market Cap, Operating Margin.

Key Dynamics to Monitor

MMED profiles as a turnaround stock while OMDA is a hypergrowth play — different risk/reward profiles.

OMDA is growing revenue faster at 58.1% — sustainability is the question.

OMDA generates stronger free cash flow (21M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MMED scores higher overall (37/100 vs 37/100) and 13.1% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MiniMed Group, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

Omada Health, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Omada Health, Inc. provides a range of virtual care programs in the United States. The company is headquartered in San Francisco, California.

Visit Website →

Want to dig deeper into these stocks?